Filing Details
- Accession Number:
- 0001808805-21-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-16 17:12:52
- Reporting Period:
- 2021-08-12
- Accepted Time:
- 2021-08-16 17:12:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808805 | Nautilus Biotechnology Inc. | NAUT | Blank Checks (6770) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856938 | Anna Mowry | C/O Nautilus Biotechnology, Inc. 425 Pontius Ave N, Ste 202 Seattle WA 98109 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-12 | 17,500 | $7.71 | 17,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $7.60 to $7.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
